| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 23 Jan 2025 | 10 Jan 2025 |
| Senores Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2025 inter alia to consider and approve Unaudited and Consolidated Financial Results of the Company for quarter and nine months ended December 31 2024 and to transact any other business matters. Outcome of Board Meeting Senores Pharmaceuticals Ltd has informed BSE regarding Appointment of Secretarial Auditor for FY 2024_]2025 Integrated Filing (Financial) for the quarter and nine months ended December 31, 2024. (As Per BSE Announcement Dated on 23/01/2025) | ||
Senores Pharmaceuticals intends to fund the acquisition through proceeds from its IPO, which raised ₹5.82 billion in December.
Senores Pharmaceuticals shares closed 6% below their listing price, although they are still up 43% from the IPO price.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
